Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Fixed Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.880.800.811.131.32

What is the latest Fixed Capital/Sales ratio of NATCO PHARMA ?

The latest Fixed Capital/Sales ratio of NATCO PHARMA is 0.88 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.88
Mar20250.80
Mar20240.81
Mar20231.13
Mar20221.32

How is Fixed Capital/Sales of NATCO PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.88
10.00
Mar2025 0.8
-1.23
Mar2024 0.81
-28.32
Mar2023 1.13
-14.39
Mar2022 1.32 -

Other Financial Ratios of NATCO PHARMA


Compare Fixed Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,543.0 Cr 0.9% -2% -3.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹108,012.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.9%

-2%

-3.6%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses